Septerna is a clinical stage biotech company developing oral small molecule medicines that target G protein coupled receptors. It last closed at $38.61 on Nov 20, down 1.51% on the day. The next earnings report for SEPN is expected around Mon, Mar 8, 2027, after the close. For the quarter ended Sep 2026, SEPN reported EPS of -$0.57 on revenue of $18.9M, with revenue down 12.2% from a year ago. Over its last 8 reports the stock moved an average of 5.6% the session after earnings. Over the last 12 months SEPN insiders bought $0 of stock on the open market and sold $74.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is SEPN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SEPN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SEPNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SEPN · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 15% below its 20 day and 5% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 40). The nearest support is the swing low (Oct 26) at $38.39, and the nearest resistance the swing high (Oct 9) at $38.73.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 7.7%/day
Key levels
$53.3452 week high+38.2%
$44.2520 day average+14.6%
$40.6850 day average+5.4%
$39.59Pivot R1+2.5%
$39.21100 day average+1.6%
$38.91Pivot+0.8%
$38.73Swing high (Oct 9)+0.3%
$38.61Last close
$38.39Swing low (Oct 26)−0.6%
$37.93Pivot S1−1.8%
$33.50200 day average−13.2%
$22.7852 week low−41.0%
Indicators
RSI (14)
39.96
Weak, oversold below 30
Neutral
MACD
-0.21
Below its signal line
Bearish
Stochastic
2.8
Near the bottom of its range
Oversold
ADX (14)
15.4
No clear trend
Williams %R
-97.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-119.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−21.0%
Change over 10 sessions
Bearish
ATR (14)
$2.96
Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 14.1%/day
Key levels
$53.3452 week high+38.2%
$44.2520 day average+14.6%
$40.6850 day average+5.4%
$39.59Pivot R1+2.5%
$39.21100 day average+1.6%
$38.91Pivot+0.8%
$38.73Swing high (Oct 9)+0.3%
$38.61Last close
$38.39Swing low (Oct 26)−0.6%
$37.93Pivot S1−1.8%
$33.50200 day average−13.2%
$22.7852 week low−41.0%
Indicators
RSI (14)
52.18
Middle of its range
Neutral
MACD
3.00
Below its signal line
Bearish
Stochastic
51.1
Middle of its range
Neutral
ADX (14)
41.3
Strong uptrend
Williams %R
-77.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
21.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.3%
Change over 10 sessions
Bullish
ATR (14)
$5.45
Typical daily range, 14.1% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for SEPN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SEPN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SEPNHow many large options trades hit SEPN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SEPN in the last 90 days.
From SEC Form 4 filings by SEPN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SEPN is in one of them and how their past SEPN trades turned out.
Septerna is a clinical stage biotechnology company based in South San Francisco, California. It uses its Native Complex Platform to discover oral small molecule medicines that act on G protein coupled receptors, a large family of proteins that help control many processes in the body. Its pipeline is focused on endocrine diseases, immune and inflammatory conditions, and metabolic diseases. The company aims to develop these medicines for patients with significant unmet medical needs.